| |
| |
|
| Insider
Information: |
Mueller Peter |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
311,837 |
|
|
Indirect Shares
|
25,571 |
|
|
| Direct
Value |
$68,363,700 |
|
|
|
Indirect Value
|
$12,144,946 |
|
|
| Total
Shares |
337,408 |
|
|
| Total
Value |
$80,508,646 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Global R&D, CSO |
2014-06-16 |
143,517 |
2014-06-16 |
25,571 |
Premium* |
|
|
Bioxcel Therapeutics Inc |
BTAI |
Director |
2019-08-23 |
168,320 |
2018-12-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2013-12-16 |
4 |
OE |
$28.84 |
$216,300 |
D/D |
7,500 |
149,000 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-01-15 |
4 |
OE |
$28.84 |
$216,300 |
D/D |
7,500 |
149,000 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-01-15 |
4 |
AS |
$78.67 |
$590,025 |
D/D |
(7,500) |
141,500 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-02-05 |
4 |
A |
$0.01 |
$173 |
D/D |
17,250 |
158,750 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-02-18 |
4 |
OE |
$28.84 |
$216,300 |
D/D |
7,500 |
166,250 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-02-18 |
4 |
AS |
$82.55 |
$619,442 |
D/D |
(7,500) |
158,750 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-03-17 |
4 |
OE |
$28.84 |
$216,300 |
D/D |
7,500 |
166,250 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-03-17 |
4 |
AS |
$78.19 |
$587,145 |
D/D |
(7,500) |
158,750 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-04-15 |
4 |
AS |
$60.57 |
$462,207 |
D/D |
(7,500) |
158,750 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-04-15 |
4 |
OE |
$28.84 |
$235,390 |
D/D |
7,500 |
166,250 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-05-14 |
4 |
AS |
$66.13 |
$505,849 |
D/D |
(7,500) |
143,517 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-05-14 |
4 |
OE |
$32.16 |
$241,200 |
D/D |
7,500 |
151,017 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-06-16 |
4 |
OE |
$32.16 |
$241,200 |
D/D |
7,500 |
151,017 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Global R&D, CSO |
• – – |
2014-06-16 |
4 |
AS |
$67.72 |
$512,352 |
D/D |
(7,500) |
143,517 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-06 |
4 |
AS |
$30.78 |
$37,336 |
D/D |
(1,213) |
73,331 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-02 |
4 |
A |
$0.01 |
$122 |
D/D |
12,200 |
85,531 |
|
- |
|
141 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
